These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 458151)

  • 1. Effect of glucan on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activities.
    Lotzová E; Gutterman JU
    J Immunol; 1979 Aug; 123(2):607-11. PubMed ID: 458151
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine antibody-dependent cell-mediated cytotoxicity: failure to detect effector cells equivalent to human K cells.
    Tada M; Hinuma S; Abo T; Kumagai K
    J Immunol; 1980 Apr; 124(4):1929-36. PubMed ID: 7365244
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallelism between the effect of cortisone acetate on hybrid resistance and natural killing.
    Lotzová E; Savary CA
    Exp Hematol; 1981 Aug; 9(7):766-74. PubMed ID: 7032960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
    Bilge A; Pollack SB
    Nat Immun; 1992; 11(3):156-66. PubMed ID: 1392403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo effects of steel factor on natural killer lineage cells in murine spleen and bone marrow.
    Miller SC; Fleming WH; Zsebo KM; Weissman IL
    Nat Immun; 1993; 12(6):293-301. PubMed ID: 7505667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts.
    Hochman PS; Cudkowicz G
    J Immunol; 1977 Dec; 119(6):2013-5. PubMed ID: 334980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic control of the generation of mature natural killer lymphocytes in bone marrow and spleen of the mouse.
    Belluardo N; Mudó G; Cardile V; Migliorati G; Riccardi C; Cella S; Bindoni M
    Nat Immun Cell Growth Regul; 1990; 9(1):26-35. PubMed ID: 2184351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of natural killer cells from bone marrow precursors in vitro.
    Kalland T
    Immunology; 1986 Apr; 57(4):493-8. PubMed ID: 3485566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
    Azuma E; Kaplan J
    J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of natural killer cell on hematopoiesis and immunity recovery in mouse allogeneic bone marrow transplantation].
    Yang ZG; Zeng YY; He XH; Wang Q; Jiang X
    Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):713-6. PubMed ID: 15730711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level.
    Kalland T
    J Immunol; 1990 Jun; 144(11):4472-6. PubMed ID: 2341727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL; Kumar V; Koo G; Bennett M
    J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of NK cell activity in thymectomized bone marrow chimaeras.
    Sihvola M; Hurme M
    Immunology; 1984 Sep; 53(1):17-22. PubMed ID: 6147307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.